The quarantine authorities announced that they are considering the introduction of the new coronavirus infection (Corona 19) vaccine’Sputnik V’developed in Russia in Korea.
Chung Eun-kyung, the Centers for Disease Control and Prevention of the Centers for Disease Control and Prevention, said at a regular briefing on Corona 19 on the afternoon of the 8th. It is scheduled”.
Sputnik V is a vaccine that has been shown to have an effect of 91.6% as a result of the recently published phase 3 clinical trial. As the results are published in international medical journals, the evaluation of vaccines is also changing. It has been pointed out that safety concerns have been raised, but according to the paper, no serious side effects related to the vaccine were found. Russia expects the vaccine to be approved by the European Union.
The vaccine price is also around $20 (about 22,300 won), which is evaluated as being competitive compared to Pfizer and Modena.
Earlier, the authorities said at a regular briefing on the 4th that “the Agency for Disease Control and Prevention is not currently discussing for an introduction contract.” It seems to have turned around in four days.
The review of the introduction of the NovaVax vaccine, a US pharmaceutical company, continues. “In addition to the currently purchased 56 million people, we are continuing to review the introduction of NovaVax vaccine.” I am planning.”
However, he said, “We will open all the possibilities and put all vaccines as candidates for review.”
Wooyeol Yoon, reporter of Donga.com [email protected]
–
